Navigation Links
Saquinavir in Medical News

AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances

...ns and therapeutic effects of those antiretroviral drugs may be reduced. NEXIUM may increase the plasma levels of saquinavir. Dose reduction of saquinavir should be considered. NEXIUM should be used only for the conditions, dosages, and durations specified in the Prescribing Information. For a...

Roche Engages in Four Additional AIDS Technology Transfers to Strengthen Local Manufacturing in World's Poorest Countries

... expertise required to produce generic HIV medicines. Manufacturers in sub-Saharan Africa and the Least Developed Countries wishing to produce generic saquinavir for use in these countries will not be required to apply for a voluntary license because Roche has committed as part of its global policy not to enfor...

Antiretroviral Drugs: A Shot in the Arm to Fight Malaria?

...ium falciparum in vitro. The finding revealed that serum taken from people who were undergoing antiretroviral therapy, consisting of ritonavir-boosted saquinavir (Invirase) or lopinavir (Kaletra), showed remarkable anti-malarial activity. The presence of nelfinavir (Viracept), amprenavir (Agenerase) and the NN...

Roche offers HIV drug expertise to poor nations

...Saharan Africa and the Least Developed Countries wishing to produce generic saquinavir for use in these countries. Unconvinced However, the Bern Decl... to renounce its patents in these countries. Reinhard also claimed that saquinavir was never prescribed on its own, but usually in combination with the drug R...

Garlic Supplements Impede HIV Therapy

...nce of garlic supplements, blood concentrations of saquinavir decreased by about 50 percent. For the study,...unteers' blood to measure their baseline levels of saquinavir in the bloodstream. Next, the volunteers took garl...lyzed blood samples, the average overall levels of saquinavir had decreased 50 percent. The clear implicat...
Saquinavir in Medical Technology

AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product

... and therapeutic effects of those antiretroviral drugs may be reduced . NEXIUM may increase the plasma levels of saquinavir. Dose reduction of saquinavir should be considered. Please see full Prescribing Information for NEXIUM . For additional information, questions, or to request a copy of...

Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer

...ding doses of SPI-452 administered alone and in combination with 1000 mg of saquinavir (SQV). In part 1 of the study, subjects received single doses of SPI-452 (2...from this study demonstrated that SPI-452 increased mean exposure levels of saquinavir which was early validation that SPI-452 was a potent pharmacokinetic enhanc...

European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection

...ation antiretroviral therapy, including the components of ATRIPLA (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate [DF] 300 mg). saquinavir should not be used as the only protease inhibitor in combination with ATRIPLA. Coadministration of ATRIPLA and atazanavir is not recommended due to ...

Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe

... Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy, including the components of ATRIPLA. saquinavir should not be used as the only protease inhibitor in combination with ATRIPLA. Coadministration of ATRIPLA and atazanavir is not recommended due to ...

European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)

.... Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy, including the components of ATRIPLA. saquinavir should not be used as the only protease inhibitor in combination with ATRIPLA. Coadministration of ATRIPLA and atazanavir is not recommended due to c...

Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV

.... Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy, including the components of ATRIPLA. saquinavir should not be used as the only protease inhibitor in combination with ATRIPLA. Coadministration of ATRIPLA and atazanavir is not recommended due to c...

Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA

...I (CPI/r) that offered patients the best opportunity for treatment response based on resistance testing. The comparator PIs were lopinavir, indinavir, saquinavir and amprenavir. In addition, patients in both arms received an optimized background regimen of other antiretroviral drugs. Patients were treatment-exp...
Saquinavir in Medical Definition

Sexual orientation and medicine

...o-dystonic homosexuality. 1993 Dr. Dean Hamer publishes a paper suggesting a genetic component to sexual orientation. [3] 1995 saquinavir , the first protease inhibitor is approved for public use by the FDA . HAART radically changes the prognosis of HIV/AIDS . 1996 The US ...
Saquinavir in Biological News

Virtual human in HIV drug simulation

... The study, published online today in the Journal of the American Chemical Society, ran a large number of simulations to predict how strongly the drug saquinavir would bind to three resistant mutants of HIV-1 protease, a protein produced by the virus to propagate itself. These protease mutations are associated ...
Other Tags
(Date:9/2/2015)... ... September 02, 2015 , ... ... patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions ... Series. The series enables pharmaceutical researchers to participate in interactive programs in ...
(Date:9/2/2015)... ... 02, 2015 , ... RxNT , an innovative software ... enhanced, cloud-based mobile ePrescribing application. The release of this enhanced iPhone app marks ... leader in health technology, RxNT was one of the first to build an ...
(Date:9/2/2015)... Covington, LA (PRWEB) , ... September 02, 2015 ... ... new President/CEO and Regulatory Affairs Officer following the departure of Kristen Dietz, former ... Medical Officer of Healtec® released the following statement welcoming Mr. Salot: “ Stanley ...
(Date:9/2/2015)... ... 02, 2015 , ... Splashtop Inc., the worldwide leader in ... mirroring and extending product line -- Splashtop Wired XDisplay . Complementing ... setting, the new Splashtop Wired XDisplay delivers enhanced performance and reliability for users ...
(Date:9/2/2015)... ... September 02, 2015 , ... Care Providers and their ... documents that include EOBs, payments, and payment related documents. AD-EOB A/R helps them ... reconcile their billing, with one efficient process and interface,“ stated Rich Caproni, AliusDoc’s ...
Breaking Medicine News(10 mins):Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 3Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2Health News:Healtec® Announces Executive Leadership Change 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2
(Date:8/31/2015)... , August 31, 2015 ... biometrics technology in government digitization projects to drive ... a recently published TechSci Research report, " India Biometrics Market ... India is projected to grow at a CAGR ... market is anticipated on account of extensive use of biometric ...
(Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015  Sarcos ... today it will unveil its "Guardian S" snake robot, ... National Tactical Officers Association Conference on August 30 in ... is the first-ever commercially available energetically autonomous snake robot, ... in-field trials and is protected by more than 50 ...
(Date:8/20/2015)... CLARA, Calif. , Aug. 20, 2015 /PRNewswire/ ... company focused on improving the user experience and ... and vision technologies, today announced that its ... voice biometric authentication software to be FIDO ... tested TrulySecure for compliance with the FIDO UAF ...
Breaking Biology News(10 mins):India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 2India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 3Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5
Other Contents